prognostic factors

You have access
Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib
NAOKI FUKUDA, KAZUHISA TODA, AKIHIRO OHMOTO, XIAOFEI WANG, NAOMI HAYASHI, TETSUYA URASAKI, YASUYOSHI SATO, KENJI NAKANO, MAKIKO ONO, JUNICHI TOMOMATSU, HIROKI MITANI and SHUNJI TAKAHASHI

Anticancer Research March 2021, 41 (3) 1683-1691; DOI: https://doi.org/10.21873/anticanres.14932
You have access
Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes
ELINA URPILAINEN, REETTA ARIMA, PEETER KARIHTALA, ULLA PUISTOLA and ANNE AHTIKOSKI

Anticancer Research February 2021, 41 (2) 821-828; DOI: https://doi.org/10.21873/anticanres.14834
You have access
Palliative Thoracic Radiotherapy for Non-small Cell Lung Cancer: Is There any Impact of Target Volume Size on Survival?
CARSTEN NIEDER, KRISTIAN S. IMINGEN, BARD MANNSAKER and ROSALBA YOBUTA

Anticancer Research January 2021, 41 (1) 355-358; DOI: https://doi.org/10.21873/anticanres.14783
You have access
Oncological Outcome and Prognostic Factors of Surgery for Soft Tissue Sarcoma After Neoadjuvant or Adjuvant Radiation Therapy: A Retrospective Analysis over 15 Years
HEINRICH M.L. MUEHLHOFER, BENJAMIN SCHLOSSMACHER, ULRICH LENZE, FLORIAN LENZE, RAINER BURGKART, ALEXANDRA S. GERSING, JAN C. PEEKEN, STEPHANIE E. COMBS, RUEDIGER VON EISENHART-ROTHE and CAROLIN KNEBEL

Anticancer Research January 2021, 41 (1) 359-368; DOI: https://doi.org/10.21873/anticanres.14784
You have access
EZH2 Expression in Follicular Lymphoma Is Variable and Independent from the Progression of Disease Within 24 Months of First Treatment
ANNA SZUMERA-CIEĆKIEWICZ, JAN POLESZCZUK, EWA PASZKIEWICZ-KOZIK, GRZEGORZ RYMKIEWICZ, KAMIL SOKÓŁ, ANITA BORYSIUK, MARTYNA KOTARSKA, DARIA OWCZAREK, MONIKA KAWECKA, BEATA PYTLAK, JAN WALEWSKI and MONIKA PROCHOREC-SOBIESZEK

Anticancer Research December 2020, 40 (12) 6685-6697; DOI: https://doi.org/10.21873/anticanres.14692
You have access
Prognostic Factors of Local Control and Survival in Patients Irradiated for Glioblastoma Multiforme (GBM)
JASPAR WITTELER, STEVEN E. SCHILD and DIRK RADES

Anticancer Research December 2020, 40 (12) 7025-7030; DOI: https://doi.org/10.21873/anticanres.14728
You have access
Re-Irradiation for Recurrent Glioblastoma Multiforme
DIRK RADES, JASPAR WITTELER, JAN LEPPERT and STEVEN E. SCHILD

Anticancer Research December 2020, 40 (12) 7077-7081; DOI: https://doi.org/10.21873/anticanres.14735
You have access
Re-Evaluation of Prognostic Factors for Survival After Radiotherapy of Cerebral Gliomas: A Supplementary Analysis to a Previous Study
JASPAR WITTELER, TROELS W. KJAER, SOEREN TVILSTED, STEVEN E. SCHILD and DIRK RADES

Anticancer Research November 2020, 40 (11) 6513-6515; DOI: https://doi.org/10.21873/anticanres.14674
You have access
Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy
TOMOAKI KUROKAWA, YOICHI HAMAI, MANABU EMI, YUTA IBUKI, TORU YOSHIKAWA, MANATO OHSAWA, RYOSUKE HIROHATA and MORIHITO OKADA

Anticancer Research August 2020, 40 (8) 4387-4394; DOI: https://doi.org/10.21873/anticanres.14442
You have access
Prognostic Factors for Endometrial and Cervical Cancers of Uterus Treated With Immune-cell Therapy: A Retrospective Study
RISHU TAKIMOTO, TAKASHI KAMIGAKI, SACHIKO OKADA, HIROSHI IBE, ERI OGUMA, KEIKO NAITOH, KAORI MAKITA, KOSEI YASUMOTO and SHIGENORI GOTO

Anticancer Research August 2020, 40 (8) 4729-4740; DOI: https://doi.org/10.21873/anticanres.14474

Main menu

User menu

Search

prognostic factors

Pages